Literature DB >> 35589395

Depolarizing NaV and hyperpolarizing KV channels are co-trafficked in sensory neurons.

Grant P Higerd-Rusli1,2,3,4, Matthew Alsaloum1,2,3,4, Sidharth Tyagi1,2,3,4, Nivedita Sarveswaran2,3,4, Mark Estacion2,3,4, Elizabeth J Akin2,3,4, Fadia B Dib-Hajj2,3,4, Shujun Liu2,3,4, Daniel Sosniak2,3,4, Peng Zhao2,3,4, Sulayman D Dib-Hajj5,3,4, Stephen G Waxman5,3,4.   

Abstract

Neuronal excitability relies on coordinated action of functionally distinct ion channels. Voltage-gated sodium (NaV) and potassium (KV) channels have distinct but complementary roles in firing action potentials: NaV channels provide depolarizing current while KV channels provide hyperpolarizing current. Mutations and dysfunction of multiple NaV and KV channels underlie disorders of excitability, including pain and epilepsy. Modulating ion channel trafficking may offer a potential therapeutic strategy for these diseases. A fundamental question, however, is whether these channels with distinct functional roles are transported independently or packaged together in the same vesicles in sensory axons. We have used Optical Pulse-Chase Axonal Long-distance (OPAL) imaging to investigate trafficking of NaV and KV channels and other axonal proteins from distinct functional classes in live rodent sensory neurons (from male and female rats). We show that, similar to NaV1.7 channels, NaV1.8 and KV7.2 channels are transported in Rab6a-positive vesicles, and that each of the NaV channel isoforms expressed in healthy, mature sensory neurons - NaV1.6, NaV1.7, NaV1.8, and NaV1.9 - are co-transported in the same vesicles. Further, we show that multiple axonal membrane proteins with different physiological functions - NaV1.7, KV7.2, and TNFR1 - are co-transported in the same vesicles. However, vesicular packaging of axonal membrane proteins is not indiscriminate, since another axonal membrane protein - NCX2 - is transported in separate vesicles. These results shed new light on the development and organization of sensory neuron membranes, revealing complex sorting of axonal proteins with diverse physiological functions into specific transport vesicles.Significance StatementNormal neuronal excitability is dependent on precise regulation of membrane proteins including NaV and KV channels, and imbalance in the level of these channels at the plasma membrane could lead to excitability disorders. Ion channel trafficking could potentially be targeted therapeutically, which would require better understanding of the mechanisms underlying trafficking of functionally diverse channels. Optical Pulse-chase Axonal Long-distance (OPAL) imaging in live neurons permitted examination of the specificity of ion channel trafficking, revealing co-packaging of axonal proteins with opposing physiological functions into the same transport vesicles. This suggests that additional trafficking mechanisms are necessary to regulate levels of surface channels and reveals an important consideration for therapeutic strategies that target ion channel trafficking for the treatment of excitability disorders.
Copyright © 2022 the authors.

Entities:  

Year:  2022        PMID: 35589395      PMCID: PMC9188389          DOI: 10.1523/JNEUROSCI.0058-22.2022

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  74 in total

1.  Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-04       Impact factor: 5.182

2.  MAP2 Defines a Pre-axonal Filtering Zone to Regulate KIF1- versus KIF5-Dependent Cargo Transport in Sensory Neurons.

Authors:  Laura F Gumy; Eugene A Katrukha; Ilya Grigoriev; Dick Jaarsma; Lukas C Kapitein; Anna Akhmanova; Casper C Hoogenraad
Journal:  Neuron       Date:  2017-04-19       Impact factor: 17.173

3.  Screening Assay Protocols Targeting the Nav1.7 Channel Using Qube High-Throughput Automated Patch-Clamp System.

Authors:  Binbin Qian; Sung Hoon Park; Weifeng Yu
Journal:  Curr Protoc Pharmacol       Date:  2020-06

Review 4.  Potassium channels in neuropathic pain: advances, challenges, and emerging ideas.

Authors:  Jérôme Busserolles; Christoforos Tsantoulas; Alain Eschalier; José A López García
Journal:  Pain       Date:  2016-02       Impact factor: 6.961

Review 5.  Status of peripheral sodium channel blockers for non-addictive pain treatment.

Authors:  Matthew Alsaloum; Grant P Higerd; Philip R Effraim; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2020-10-27       Impact factor: 42.937

6.  Transfection of rat or mouse neurons by biolistics or electroporation.

Authors:  Sulayman D Dib-Hajj; Jin Sung Choi; Lawrence J Macala; Lynda Tyrrell; Joel A Black; Theodore R Cummins; Stephen G Waxman
Journal:  Nat Protoc       Date:  2009-07-09       Impact factor: 13.491

7.  A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy.

Authors:  Matthew Alsaloum; Mark Estacion; Rowida Almomani; Monique M Gerrits; Gidon J Bönhof; Dan Ziegler; Rayaz Malik; Maryam Ferdousi; Giuseppe Lauria; Ingemar Sj Merkies; Catharina G Faber; Sulayman Dib-Hajj; Stephen G Waxman
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 8.  Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain.

Authors:  Alaa Abd-Elsayed; Markus Jackson; Steven L Gu; Kenneth Fiala; Jianguo Gu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

9.  Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn.

Authors:  Joel A Black; Noémie Frézel; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Mol Pain       Date:  2012-11-07       Impact factor: 3.395

10.  A novel gain-of-function sodium channel β2 subunit mutation in idiopathic small fiber neuropathy.

Authors:  Matthew Alsaloum; Julie I R Labau; Daniel Sosniak; Peng Zhao; Rowida Almomani; Monique Gerrits; Janneke G J Hoeijmakers; Giuseppe Lauria; Catharina G Faber; Stephen G Waxman; Sulayman Dib-Hajj
Journal:  J Neurophysiol       Date:  2021-07-28       Impact factor: 2.974

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.